USA / Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
In 2020, the US FDA’s Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in…
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical…
As the only country in the world to boast a universal healthcare system that…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
With the onset of universal public healthcare, new types of foreign actors have…
The Brazilian pharma market outperformed the Latin American average in Q1 of…
Six of the top ten companies in the Brazilian pharma market are domestic.* Read…
Puerto Rico had to rebuild itself – in many cases quite literally – after…
When life sciences companies decide to transfer the production of new drug to…
With Rare Disease Day coming up on February 28th, one of the leading…
The AAM’s Dan Leonard highlights the savings impact that generic and…
The latest from Mexico’s fight against COVID-19, including news of vaccine…
COVID-19 has highlighted the importance of secure regional pharma supply chains…
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and…
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over…
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the…
A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from…